1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Random Allocation: new trials by email Literature Review of Random Allocation trials Research Report on Random Allocation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant CCRT With/Without Bevacizumab for Locally Advanced ESCC BPF-CCRT (run-in), BPF-CCRT (randomized), PF-CCRT (randomized) - Stage III Esophageal Squamous Cell Carcinoma | Phase 2 | Unknown | National Taiwan University Hospital | 50 | 2016-06-01 | 2019-03-11 |
Esophageal Squamous Cell Carcinoma (1)
National Taiwan University Hospital (1)
Taiwan (1)